The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeGrowth
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LSVVX | 15.03 | N/A | N/A |
LSV Conservative Value Equity | |||
MIDRX | 32.58 | N/A | N/A |
MFS International New Discovery R2 | |||
MNBAX | 20.62 | N/A | N/A |
Manning & Napier Pro-Blend Extnd Term S | |||
ETNHX | 39.15 | N/A | N/A |
Eventide Healthcare & Life Sciences N | |||
MUSBX | 37.43 | -0.10 | -0.27% |
MFS Blended Research Core Equity B |
A.I.dvisor indicates that over the last year, TSNCX has been closely correlated with VIGRX. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNCX jumps, then VIGRX could also see price increases.
Ticker / NAME | Correlation To TSNCX | 1D Price Change % | ||
---|---|---|---|---|
TSNCX | 100% | N/A | ||
VIGRX - TSNCX | 95% Closely correlated | N/A | ||
VIGIX - TSNCX | 95% Closely correlated | N/A | ||
VIGAX - TSNCX | 95% Closely correlated | N/A | ||
RGACX - TSNCX | 89% Closely correlated | +0.07% | ||
RGEBX - TSNCX | 89% Closely correlated | +0.07% | ||
More |